High Tide Welcomes White House Executive Order Advancing Cannabis Rescheduling
High Tide welcomed the Executive Order issued by the White House advancing the rescheduling of cannabis as well as an announcement that the Centers for Medicare & Medicaid Services is expected to launch a pilot program allowing certain Medicare beneficiaries to receive CBD treatments at no cost. "Given the imminent move toward cannabis rescheduling, the Company has begun evaluating the feasibility of expanding its flagship bricks-and-mortar retail brand, Canna Cabana, into the United States through a licensing model. In parallel, the Company's hemp-derived CBD brands, NuLeaf Naturals and FAB CBD, are well-positioned to benefit from rescheduling and the potential inclusion of CBD products within Medicare Advantage supplemental benefits. This positioning is supported by THC-free and broad-spectrum product formats that align with compliant Medicare benefit catalogs, CGMP-certified operations, and USDA organic product certifications. NuLeaf's breadth, scale, and premium positioning enable long-term category leadership through a dedicated, Medicare-ready offering, while FAB's purpose-driven, simplified dosing assortment is designed to support faster adoption across Medicare Advantage plans. Both NuLeaf and FAB will begin evaluating Medicare-aligned product categories as a result of today's news. In addition, the Company is pleased to announce that it has reengaged IR Agency effective December 19, 2025, to provide investor relations services, supporting the Company's communications with existing and prospective shareholders, the investment community and stakeholders," the company stated.
Trade with 70% Backtested Accuracy
Analyst Views on HITI
About HITI
About the author
High Tide (HITI) to Announce Q4 Earnings on January 29
- Earnings Announcement Date: High Tide (HITI) is set to release its Q4 earnings on January 29 after market close, with a consensus EPS estimate of $0.01, reflecting a significant year-over-year increase of 116.7%, indicating improved profitability.
- Revenue Expectations Decline: Despite the optimistic EPS forecast, the revenue estimate stands at $116.1 million, representing a 16.1% year-over-year decline, suggesting increased market competition and sales pressure may impact overall performance.
- Historical Performance Review: Over the past two years, HITI has only beaten EPS estimates 13% of the time, yet has exceeded revenue estimates 100% of the time, indicating strong revenue management despite fluctuations in profitability.
- Market Attention: As a discount cannabis retailer, High Tide's hidden position in the market, despite facing challenges, may present unique opportunities for investors, warranting close attention to its future financial performance and market strategies.
High Tide Inc. Reports Q4 Earnings Results
- Earnings Highlights: High Tide Inc. reported a Q4 Non-GAAP EPS of C$0.02, indicating limited profitability but demonstrating the company's stability in the market.
- Revenue Growth: The company achieved Q4 revenue of C$164.03 million, representing an 18.6% year-over-year increase, which highlights significant sales growth in the competitive discount cannabis retail market.
- Market Position: As a discount cannabis retailer, High Tide Inc. maintains a relatively hidden competitive advantage despite industry challenges, attracting investor interest.
- Quant Rating: Seeking Alpha's Quant Rating on High Tide Inc. reflects cautious optimism regarding its future performance, indicating investor concern over its financial health.
